Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
TerminatedPhase 4NCT01841931
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence of opioid withdrawal symptoms and improved quality of life.
Study details
- Official title
- Buprenorphine Tx:A Safe Alternative for Opioid Dependent Pain Patients
- Interventions
- Drug: Buprenorphine/Naloxone
- Sponsor
- Theresa Jacob, PhD, MPH
- Organization
- Maimonides Medical Center
- Start date
- 2013-02
- Primary completion
- 2013-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Meets DSM criteria for opioid dependence (or opioid use disorder when DSM 5 is in use) * Has received opioid therapy for at least 90 days * Has opioid dependence as assessed by a Maimonides psychiatrist Exclusion Criteria: * Scheduled for major surgery during study duration * Predicted life expectancy \< 1 year * Plan to cease habitation in greater New York area within 6 months * Risks for buprenorphine outweigh potential benefit, as determined by the PI * Lacks sufficient fluency in English to understand the study protocol, answer survey questions or give informed consent * Pregnant women
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01841931